Clinical Trial Update: Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tezampanel for opioid withdrawal in treatment-seeking patients with opioid use disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Tezampanel (tezampanel)

Snippet

Sponsor: Proniras Corporation | Conditions: Opioid Use Disorder | Phase 1 | Status: RECRUITING